Petros Pharmaceuticals Inc (PTPI) — Capital Reinvestment Ratio
Petros Pharmaceuticals Inc (PTPI) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow ($965.40K) in capital expenditures ($5.45K). Check Petros Pharmaceuticals Inc (PTPI) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Petros Pharmaceuticals Inc Capital Reinvestment Ratio (2018–2019)
This chart tracks Petros Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see PTPI operating cash flow.
Annual Capital Reinvestment Ratio for Petros Pharmaceuticals Inc (2018–2019)
Year-by-year Capital Reinvestment Ratio for Petros Pharmaceuticals Inc from 2018 to 2019. See free cash flow generation of Petros Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | $2.53 Million | $71.54K | ▼ -87.9% |
| 2018 | 0.23x | $8.02 Million | $1.88 Million | — |